Inhibition of the glycine transporter GlyT‐1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex

Glycine potentiates the NMDA response in cultured mouse brain neurons

1987 • 3,116 citations

Recent advances in the phencyclidine model of schizophrenia

1991 • 2,886 citations

Glutamate Receptor Dysfunction and Schizophrenia

1995 • 1,682 citations

Functional and Anatomical Aspects of Prefrontal Pathology in Schizophrenia

1997 • 665 citations

Genes for schizophrenia? Recent findings and their pathophysiological implications

2003 • 610 citations

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

1996 • 440 citations

A Placebo-Controlled Trial of D-Cycloserine Added to Conventional Neuroleptics in Patients With Schizophrenia

1999 • 435 citations

Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors

1992 • 428 citations

Glutamate receptor expression in schizophrenic brain

2000 • 401 citations

D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia

2005 • 378 citations

Ionotropic Glutamate Receptors and Expression ofN-Methyl-<scp>d</scp>-Aspartate Receptor Subunits in Subregions of Human Hippocampus: Effects of Schizophrenia

2000 • 366 citations

Glycine transporter I inhibitor, N-Methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia

2004 • 335 citations

A “Glutamatergic Hypothesis” of Schizophrenia

1989 • 270 citations

Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant Schizophrenia

1996 • 253 citations

Glycine Tranporter-1 Blockade Potentiates NMDA-Mediated Responses in Rat Prefrontal Cortical Neurons In Vitro and In Vivo

2003 • 230 citations

<scp>d-</scp>Serine Added to Clozapine for the Treatment of Schizophrenia

1999 • 224 citations

RELATIONSHIP BETWEEN EXPOSURE AND NONSPECIFIC BINDING OF THIRTY-THREE CENTRAL NERVOUS SYSTEM DRUGS IN MICE

2004 • 214 citations

High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia

2004 • 214 citations

Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs

2000 • 206 citations

Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene

1993 • 194 citations

N-Methyl-<scp>d</scp>-Aspartic Acid Receptor Expression in the Dorsolateral Prefrontal Cortex of Elderly Patients With Schizophrenia

2001 • 186 citations

A placebo-controlled crossover trial of d-cycloserine added to clozapine in patients with schizophrenia

1999 • 179 citations

Placebo-Controlled Trial of Glycine Added to Clozapine in Schizophrenia

2000 • 174 citations

Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics

2000 • 172 citations

Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro.

1997 • 158 citations

Effect of Clozapine and Adjunctive High-Dose Glycine in Treatment-Resistant Schizophrenia

1999 • 140 citations

NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder

2004 • 131 citations

Inhibition of System A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action

2004 • 131 citations

Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia

2001 • 115 citations

d-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia

2002 • 110 citations

Interaction of Dopamine D1 and NMDA Receptors Mediates Acute Clozapine Potentiation of Glutamate EPSPs in Rat Prefrontal Cortex

2002 • 109 citations

Actions of ?-cycloserine at the ? glycine receptor site in vivo

1991 • 105 citations

Combined α2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat

2005 • 80 citations

M100907, A Selective 5-HT2A Receptor Antagonist and a Potential Antipsychotic Drug, Facilitates N-Methyl-D-Aspartate-Receptor Mediated Neurotransmission in the Rat Medial Prefrontal Cortical Neurons In Vitro

1998 • 74 citations

Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex

2004 • 67 citations

Differential effects of atypical and typical antipsychotic drugs on N‐methyl‐D‐aspartate‐ and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex

2003 • 56 citations

Effects of typical and atypical antipsychotics on human glycine transporters

2004 • 46 citations

Modulation of the ability of clozapine to facilitate NMDA‐ and electrically evoked responses in pyramidal cells of the rat medial prefrontal cortex by dopamine: pharmacological evidence

2003 • 32 citations

Biphasic modulation of NMDA-induced responses in pyramidal cells of the medial prefrontal cortex by Y-931, a potential atypical antipsychotic drug

2001 • 9 citations